$6.91
-0.43-5.86%
Ult. Agg.: Nov 17, 12:35 PM
The average analyst price target for Eupraxia Pharmaceuticals is $16.71, 141.8% above the current price. Of 8 analysts, 8 rate it Buy. Targets range from $9 to $25. The latest change came on Nov 11, 2026, when HC Wainwright & Co. raised its price target on Eupraxia Pharmaceuticals from $11 to $16 and kept a Buy rating.
Price Target Range — 7 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months
